Selected References

  • American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker Muscular Dystrophy. Pediatrics 2005 116: 1569-1573.
  • American Thoracic Society. Respiratory care of the patient with Duchenne muscular dystrophy: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004 170: 456-465.
  • Bachrach LK. Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy. Neuromuscul Disord. 200515:86-87.
  • Biggar WD et al. Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention. Neuromuscul Disord 2005 15:72-9.
  • Bianchi ML, Mazzanti A et al. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int. 2003 14:761-7.
  • Bushby KMD et al. The multidisciplinary management of Duchenne muscular dystrophy. Current Paediatrics 2005 15: 292-300.
  • Bushby KMD et al. The management of cardiac complications in muscular dystrophy and myotonic dystrophy. In: Proceedings of 107th ENMC Workshop, Neuromuscul Disord 2003 13: 166-172.
  • Case, Laura. Physical therapy management of dystrophinopathies. Presented at PPMD annual conference 2006 http://www.parentprojectmd.org/site/DocServer/PT_handout-parent_project_mtg-2006-L__Case.pdf?docID=4121.
  • Daftary AS et al. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics 2007 119: e320-e324.
  • Grange RW and Call JA. Recommendations to define exercise prescription for Duchenne muscular dystrophy. Exerc. Sport Sci. Rev. 2007 35: 12-17.
  • Hinton VJ et al. Social behavior problems in boys with Duchenne muscular dystrophy. Developmental and Behavioral Pediatrics 2006 27: 470-476.
  • Muntoni F, Bushby K, Manzur AY. Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UK. Neuromuscul Disord. 2006 16: 210-219.
  • Morel-Verdebout C, Botteron S, and Kiliaridis S. Dentofacial characteristics of growing patients with Duchenne muscular dystrophy: a morphological study. The European Journal of Orthodontics 2007 29:500-507.
  • Moxley RT et al. Practice Parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005 64: 13-20.
  • Posselt, Helen, “Physical therapy: Who does what? Why do it? How often and how much? ” PPMD 2007 Conference Abstract
  • Posselt, Helen and Denny, Bev. “Aquatic physiotherapy.” Montrose Access, Brisbane Australia.
  • Poysky, J. Behavior patterns in Duchenne muscular dystrophy: Report on the Parent Project Muscular Dystrophy behavior workshop 8–9 of December 2006, Philadelphia, USA Neuromuscul Disord. 2007 17: 986-994.
  • TREAT-NMD. “Standards of care for Duchenne muscular dystrophy: Brief TREAT-NMD recommendations.” http://www.treat-nmd.eu/soc/eng/dmd/TREAT-NMD_DMD_interim_recommendations.pdf